HealthTech

NDR Medical Technology, an artificial intelligence (AI)-empowered interventional robotics company in Singapore, has on Wednesday announced that its automated robotic device automated needle targeting system (ANT)-X has been granted FDA 510(k) clearance by the United States Food and Drug Administration (FDA).

Lion TCR, a Singapore-based clinical-stage T-cell immunotherapy company, has announced the successful completion of its $40 million Series B2 financing round. Guangzhou Industrial Investment and Capital Operation Holding Group Ltd. led the financing with participation from Guangzhou Guoju Investment and CSPC NARD Capital Fund.

Prenetics Global Limited (Prenetics), a Hong Kong-based genomics-driven health sciences company, has partnered scientist Prof. Dennis Lo to establish a joint venture named Insighta for breakthrough multi-cancer early detection screening.

This prestigious competition, organized by the Guangdong-Macao in-Depth Cooperation Zone in Hengqin Economic Development Bureau, presents a lucrative opportunity for participants to showcase their talents and ideas while vying for a substantial prize pool of RMB 300 million.

New York and Singapore-based private investment firm Recharge Capital has on Thursday announced the successful closure of the first tranche of its $200 million Women’s Healthcare Investment Vehicle.

The discussion started with a light conversation over the use of modern tools like ChatGPT in healthcare. It proceeded to highlight why healthcare is a leading priority for investors in Southeast Asia. Additionally, the panel pointed out the challenges and opportunities as well as the potential for innovative technologies.

We envision Seedstars to be at the forefront of driving entrepreneurship and investment in emerging markets. We aim to expand our footprint, invest in more startups, and empower more entrepreneurs through our educational programs.

DrPrevents, a provider of preventive healthcare servicesin Malaysia, is launching its first equity crowdfunding (ECF) campaign via MyStartr. The company aims to secure MYR 4 million ($870,000), with a strategic focus on expanding the implementation of preventive medicine to complement the national public healthcare system.

Prenetics is a genomics and precision oncology company dedicated to transforming patient care through advanced genomic and molecular technologies.

Anthill Ventures, an India-based venture capital firm and speed-scaling ecosystem, has on Thursday announced the launch of a new cohort for its Lumos Health program, which is designed for startups with disruptive solutions and health technologies.